A report from the Blue Cross Blue Shield Association condemns pricing of brand-name drugs as the major driver of drug spending growth.
Read More
A report from QuintilesIMS projects "moderate" growth in drug spending through 2021.
Read More
A study in the Journal of Health Economics finds that hospitals that merge are able to reduce costs, but payers and consumers don't see the benefits.
Read More
Research carried in JAMA reviews the effect of limiting drug rep interactions with physicians on prescriptions.
Read More
A study sponsored by the Health Care Cost Institute and published in Health Affairs looks at variation in prices paid by commercial health plans.
Read More
Research carried in JAMA Internal Medicine suggests giving physicians price information doesn't change what they order.
Read More
Another study confirms that the CMS hospital readmission program is poorly designed and isn't accomplishing squat.
Read More
A Kaiser survey compares views on end-of-life care in several countries.
Read More
An AHRQ brief examines the effect of the reform law's Medicaid expansion on enrollment in employment-based insurance plans.
Read More
An analysis published in Health Affairs finds substantial turnover in physicians and beneficiaries in accountable care organizations.
Read More
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.